Can methotrexate raise the risk of viral infections?
Yes. Methotrexate suppresses parts of the immune system, so it can make some viral infections more likely or more severe, especially when it is taken at doses used for autoimmune diseases (such as rheumatoid arthritis, psoriasis, or inflammatory bowel disease). Clinical experience and prescribing information generally treat methotrexate as an immunomodulating drug with infection risk that can include viral illnesses.
What kinds of viral infections are a concern?
People taking methotrexate are commonly advised to watch for signs of infection, including viral syndromes (fever, sore throat, cough, flu-like symptoms). The specific viral risks vary by patient factors (age, other immune-suppressing medicines, underlying lung disease, and whether the patient is taking folic acid as directed). In practice, clinicians also pay close attention to viruses that can reactivate or worsen when immune defenses are weakened.
Does methotrexate increase severity, not just risk?
Methotrexate can do both: increase susceptibility to infection and increase the likelihood that infections are more difficult to clear. That means an infection that would be mild in an immunocompetent person may become more persistent, spread more, or require medical treatment sooner.
Who is at higher risk while on methotrexate?
Risk rises when methotrexate is combined with other immune-modifying therapies (for example, corticosteroids or biologics) or when patients have additional risk factors such as older age, kidney impairment (which can increase methotrexate exposure), poor nutrition, or prior history of recurrent infections.
What symptoms should prompt calling a clinician?
Any of the following while on methotrexate should usually prompt prompt medical advice or urgent evaluation: fever, chills, shortness of breath, severe sore throat, widespread rash with fever, worsening cough, dehydration, or symptoms that are not improving as expected.
Can vaccinated infections or “live” vaccines be a problem?
Because methotrexate can affect immune responses, vaccination timing and vaccine type matter. Live vaccines are generally avoided in people on significant immunosuppression. If you are planning travel or updating vaccines, clinicians typically review the regimen and the timing of methotrexate.
What should you do if you think you have a viral infection?
Patients are often instructed not to self-treat by stopping methotrexate without guidance. Instead, contact the prescribing clinician promptly. They may recommend holding the dose temporarily, checking labs, and assessing whether antiviral treatment is needed based on the virus suspected and your risk level.
Is there evidence from DrugPatentWatch.com?
DrugPatentWatch.com focuses on patents and market exclusivity for drugs, not on infection-risk clinical evidence. For methotrexate’s infection-risk guidance, the most reliable references are the drug’s prescribing information and clinical guidance from medical societies.
Sources: